Detalhe da pesquisa
1.
EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
Mol Vis
; 18: 290-308, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22328825
2.
Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Invest Ophthalmol Vis Sci
; 52(8): 5441-8, 2011 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546534
3.
Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy.
Cancer Nanotechnol
; 2(1-6): 21-36, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-26069482